Results 211 to 220 of about 2,358,049 (278)

Potential Mechanisms of Mast Cell Activation in Human Atherosclerotic Coronary Arteries [PDF]

, 2003
Laine, Petri
core  

The Pleiotropic Effect of Complement C5a-C5aR1 Pathway in Diseases: From Immune Regulation to Targeted Therapy. [PDF]

Int J Mol Sci
Xu B, Zhou Z, Xiao Y, Liu Q, Xiao T, Lv Z, Wang H.   +6 more
europepmc   +1 more source

Influence of the lysosomal elastase inhibitor eglin on development of interstitial lung edema in E. coli bacteremia in pigs [PDF]

, 1987
Jochum, Marianne, Redl, H., Schlag, G., Siebeck, Matthias, Thetter, O., Welter, H. F.   +5 more
core  

The novel B-cell epitope peptide vaccine, MAX449, exhibits significant anti-tumor efficacy and enhances the therapeutic effects of PD-1 antibodies on tumors by modulating the activity of PMN-MDSCs. [PDF]

Theranostics
Yang H, Han X, Deng B, Zhao Y, Zhao J, Wu Y, Liu G, Zeng S, Wang S, Shen Z, Wang L, Sun Z, Lu W, Wu Y, Chen J.   +14 more
europepmc   +1 more source

Dual role of complement in neuronal repair. [PDF]

Front Immunol
Lukomska A, Ciesielski P, Ratajczak MZ, Kucia M.   +3 more
europepmc   +1 more source

Chronic stress promotes pancreatic ductal adenocarcinoma progression via complement C5a-recruited myeloid-derived suppressor cells. [PDF]

Cancer Immunol Immunother
Yang S, Xiao L, Qi P, Liu Z, Chen Z, Wei R, He R, Yu Q, Yan Z, Xiong S, Wang M, Deng Y, Hu J, Zhou L, Feng Z, Deng H.   +15 more
europepmc   +1 more source

Regulation of phosphatase and tensin homolog by complement component 5a (C5a) and its receptor (C5aR1) in lupus nephritis: A novel therapeutic target. [PDF]

J Cell Commun Signal
Ma Y, Wang Y, Zhao P, Cheng L, Li L, Li R, Zhou X.   +6 more
europepmc   +1 more source

Targeting C3a and C5a Signaling-A Game Changer for Cancer Therapy? [PDF]

Biology (Basel)
Hudgins H, Molina V, Wiernicki S, Okwuegbe K, Feng X, Wang H.   +5 more
europepmc   +1 more source

Complosome Activation after Myocardial Infarction in a Murine Model of Permanent LAD Ligation. [PDF]

Stem Cell Rev Rep
Ratajczak J, Abdel-Latif A, Schneider G, Luther T, Chaudhary R, Shabani P, Lopez R, Alzamrooni A, Singh AP, Jama H, Kakar SS, Kucia M, Ratajczak M.   +12 more
europepmc   +1 more source

The free fatty acid 2 receptor regulates the activation potency of C5a and the sensitivity to the antagonist avacopan

Khan Z, Levin NK, Dahlgren C, Sundqvist M, Khan F, Forsman H, Björkman L.   +6 more
europepmc   +1 more source